IL6 and lung carcinoma: Therefore, to investigate the relationship between E2, ERβ and IL6 in lung cancer and test the hypothesis that E2 up-regulates IL6 through ERβ to promote lung cancer progression, in the present study, we demonstrate that both IL6 and ERβ expression regulate clinicopathological factors in NSCLC.